News
World-Class Clinical Research Professionals
World-Class Clinical Research Professionals Since October 2019, Arnaud Villier has been the coordinator of start-up operations at the Unit for Innovative Therapies at Montréal’s CHUM Research Centre. “It is a job where you have to make sure that each of the steps that precede the start of a clinical trial in patients is completed in accordance with good clinical practice
CATALIS Québec and AQIIRC are launching a joint advanced training bursary program
CATALIS Québec and AQIIRC are launching a joint advanced training bursary program CATALIS Québec and the Association québécoise des infirmières et intervenants en recherche clinique (AQIIRC) are launching a joint advanced training bursary program to support the development of Quebec’s clinical research professionals. Bursaries in the amount of CAN$350 each are being offered to clinical research professionals registering for the
Message from the President
Message from the President I am delighted to be joining CATALIS Québec in order to contribute to the development of clinical research in Quebec and to foster solidarity between all industry stakeholders to improve the care of patients suffering from currently incurable diseases. As the new President, I would like to take this opportunity to report on the exceptional and
Appointment of Dr. Michael Sebag to CATALIS Québec’s Board
Appointment of Dr. Michael Sebag to CATALIS Québec’s Board CATALIS Québec is pleased to announce that Dr. Michael Sebag will be joining its Board of Directors as of June 18, 2020. A researcher at the McGill University Health Centre (MUHC) since 2009, Dr. Sebag has participated in an impressive number of clinical studies which provided access to innovative treatments to
Appointment of Jacques Hendlisz as CATALIS Québec’s New Executive President
Appointment of Jacques Hendlisz as CATALIS Québec’s New Executive President CATALIS Quebec is proud to welcome Mr. Jacques Hendlisz to the organization as its new Executive President, effective April 1, 2020. Mr. Hendlisz is widely recognized for his extensive experience in the management of both research and hospital facilities. He served as the Douglas Institute’s Director General from 1994 to
COVID-19 and clinical trials : point of view of Rémi Quirion
In light of the exceptional situation surrounding COVID-19, CATALIS interviewed clinical research leaders in Quebec to find out their perspectives on the crisis and to look for ways to adapt. The following statements detail the point of view of Dr. Rémi Quirion, Chief Scientist of Quebec. Q. How do you think the COVID-19 pandemic will alter current and future clinical
COVID-19 and clinical trials : point of view of Alan Bernstein
COVID-19 and clinical trials : point of view of Alan Bernstein In light of the exceptional situation surrounding COVID-19, CATALIS interviewed clinical research leaders in Quebec to find out their perspectives on the crisis and to look for ways to adapt. The following statements detail the point of view of Alan Bernstein, President and CEO, CIFAR. Q. How do you
International Clinical Trials’ Day: Clinical Research Saves Lives
International Clinical Trials’ Day: Clinical Research Saves Lives For the International Clinical Trials’ Day, CATALIS asked the leaders in the field: “Why is clinical research essential?“ “Clinical research exposes physicians and their teams to cutting-edge technologies that help to challenge and improve current care.” “Clinical research is in the continuum of the innovation chain. Academic research laboratories are
COVID-19 and clinical trials : point of view of Dominique Johnson
COVID-19 and clinical trials : point of view of Dominique Johnson In light of the exceptional situation surrounding COVID-19, CATALIS interviewed clinical research leaders in Quebec to find out their perspectives on the crisis and to look for ways to adapt. The following statements detail the point of view of Dominique Johnson, General Manager, McPeak-Sirois Group for Clinical Research in
COVID-19 and clinical trials : point of view of Julie Autmizguine
COVID-19 and clinical trials : point of view of Julie Autmizguine In light of the exceptional situation surrounding COVID-19, CATALIS interviewed clinical research leaders in Quebec to find out their perspectives on the crisis and to look for ways to adapt. The following statements detail the point of view of Dr. Julie Autmizguine, Assistant Director of Clinical Research, Sainte-Justine UHC